Clinical Trial Update: AMG 529 First in Human Study [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study results for AMG 529 completed; cardiovascular condition investigated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• AMG 529

Snippet

Sponsor: Amgen | Conditions: Cardiovascular | Phase 1 | Status: COMPLETED | Results posted: 2019-07-05